F R Khuri Selected Research

F R Khuri Research Topics

Disease

32	Neoplasms (Cancer) 12/2017 - 02/2000
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2011 - 02/2000
9	Lung Neoplasms (Lung Cancer) 07/2014 - 03/2000
7	Squamous Cell Carcinoma of Head and Neck 05/2004 - 04/2001
6	Head and Neck Neoplasms (Head and Neck Cancer) 03/2004 - 08/2000
4	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2000
4	Carcinogenesis 04/2001 - 03/2000
3	Metaplasia 07/2001 - 08/2000
2	Thyroid Neoplasms (Thyroid Cancer) 01/2016 - 03/2013
2	Renal Insufficiency (Renal Failure) 12/2001 - 05/2001
2	Fatigue 06/2001 - 04/2001
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 05/2001 - 08/2000
1	Hemolytic Anemia 12/2017
1	Hemolysis 12/2017
1	Leukemia 12/2017
1	Inflammation (Inflammations) 10/2017
1	Melanoma (Melanoma, Malignant) 01/2016
1	Neutropenia 03/2013
1	Thrombocytopenia (Thrombopenia) 03/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2004
1	Breast Neoplasms (Breast Cancer) 06/2004
1	Residual Neoplasm 11/2001
1	Multiple Myeloma 11/2001
1	Pharyngeal Neoplasms 08/2001
1	Hypertriglyceridemia 06/2001

Drug/Important Bio-Agent (IBA)

8	Cisplatin (Platino)FDA LinkGeneric 12/2001 - 02/2000
7	Proteins (Proteins, Gene)FDA Link 10/2017 - 04/2000
5	RetinoidsIBA 08/2001 - 03/2000
4	EnzymesIBA 12/2017 - 04/2001
4	Isotretinoin (Accutane)FDA LinkGeneric 08/2001 - 03/2000
3	ErbB Receptors (EGF Receptor)IBA 06/2004 - 05/2001
3	Fluorouracil (Carac)FDA LinkGeneric 06/2001 - 08/2000
3	retinoic acid receptor betaIBA 04/2001 - 03/2000
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2017 - 05/2001
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 03/2000
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 11/2001
2	tipifarnib (R115777)IBA 08/2004 - 06/2004
2	TransferasesIBA 08/2004 - 06/2004
2	Cetuximab (Erbitux)FDA Link 11/2001 - 05/2001
2	ParaffinIBA 07/2001 - 03/2000
2	alpha-Tocopherol FDA Link 06/2001 - 03/2000
2	taxaneIBA 06/2001 - 08/2000
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2001 - 04/2001
2	LigandsIBA 05/2001 - 09/2000
1	physcioneIBA 12/2017
1	artenimol (dihydroartemisinin)IBA 12/2017
1	docosahexaenoylascorbic acid (DHA-As)IBA 12/2017
1	Antimalarials (Antimalarial Agents)IBA 12/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2017
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 12/2017
1	Phosphogluconate Dehydrogenase (Dehydrogenase, Phosphogluconate)IBA 12/2017
1	AMP-Activated Protein KinasesIBA 12/2017
1	MAP Kinase Kinase 3IBA 10/2017
1	Threonine (L-Threonine)FDA Link 10/2017
1	p38 Mitogen-Activated Protein KinasesIBA 10/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2017
1	Pyruvic Acid (Pyruvate)IBA 01/2017
1	Lactate Dehydrogenase 5IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	AntioxidantsIBA 01/2017
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 10/2016
1	StathminIBA 10/2016
1	Serine (L-Serine)FDA Link 10/2016
1	Phosphotransferases (Kinase)IBA 02/2016
1	sapanisertibIBA 02/2016
1	Mechanistic Target of Rapamycin Complex 2IBA 02/2016
1	Sterol Regulatory Element Binding Protein 1IBA 02/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2016
1	VemurafenibIBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016
1	mirdametinibIBA 01/2016
1	AZD 6244IBA 01/2016
1	conatumumabIBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2015
1	ABT-737IBA 07/2014
1	Deubiquitinating EnzymesIBA 07/2014
1	Bortezomib (Velcade)FDA Link 03/2013
1	Sunitinib (Sutent)FDA Link 03/2013
1	PlatinumIBA 08/2006
1	Estrogens (Estrogen)FDA Link 06/2004
1	Thalidomide (Thalomid)FDA Link 11/2001
1	Cytotoxins (Cytolysins)IBA 11/2001
1	Epidermal Growth Factor (EGF)IBA 11/2001
1	Gefitinib (Iressa)FDA Link 08/2001
1	Biomarkers (Surrogate Marker)IBA 07/2001
1	Hematoxylin (Haematoxylon)IBA 07/2001
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2001
1	Interferon-alpha (Interferon Alfa)IBA 06/2001
1	Docetaxel (Taxotere)FDA Link 06/2001
1	Methotrexate (Mexate)FDA LinkGeneric 06/2001
1	Taxoids (Taxanes)IBA 06/2001
1	Bexarotene (LGD1069)FDA Link 05/2001

Therapy/Procedure

12	Therapeutics 12/2017 - 04/2000
7	Drug Therapy (Chemotherapy) 08/2006 - 08/2000
7	Chemoprevention 08/2001 - 03/2000
4	Aftercare (After-Treatment) 05/2004 - 08/2000
2	Radiotherapy 11/2001 - 08/2001
1	Secondary Prevention 08/2001
1	Combined Modality Therapy 06/2001